Physician profile
Deborah Egger
NPI 1669407441
$1,207.50
in general payments reported to CMS, 2019-2025
15 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $358 · 2024: $353 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $149.92 | 2024 | Inspire |
| Mirum Pharmaceuticals, INC. | $134.66 | 2025 | Livmarli |
| Alexion Pharmaceuticals, INC. | $132.39 | 2022 | |
| Genzyme Corporation | $121.36 | 2025 | |
| Gilead Sciences, INC. | $118.33 | 2024 | Epclusa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.93 | 2025 | Xifaxan |
| Abbott Laboratories | $95.09 | 2022 | |
| Amgen INC. | $85.12 | 2024 | |
| Novo Nordisk INC | $83.03 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $47.62 | 2022 | |
| Solventum Corporation | $44.27 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Vertex Pharmaceuticals Incorporated | $38.60 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.86 | 2025 | Zilretta |
| Bioventus LLC | $17.30 | 2025 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $17.02 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Egger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.